Foundry ChTax Industry-Neutral Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1NVDA | NVIDIA CORP | Technology | $4.91T | 37.18% |
2META | META PLATFORMS INC | Communication Services | $1.64T | 12.42% |
3LLY | ELI LILLY & CO | Healthcare | $1.11T | 8.41% |
4MU | MICRON TECHNOLOGY INC | Technology | $958.80B | 7.26% |
5ABBV | ABBVIE INC | Healthcare | $449.63B | 3.41% |
6KLAC | KLA CORP | Technology | $277.91B | 2.11% |
7TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | $197.88B | 1.50% |
8AMGN | AMGEN INC | Healthcare | $197.69B | 1.50% |
9ABT | ABBOTT LABORATORIES | Healthcare | $175.37B | 1.33% |
10GILD | GILEAD SCIENCES INC | Healthcare | $166.72B | 1.26% |
11WDC | WESTERN DIGITAL CORP | Technology | $164.49B | 1.25% |
12UBER | UBER TECHNOLOGIES INC | Technology | $147.50B | 1.12% |
13DHR | DANAHER CORP | Healthcare | $144.26B | 1.09% |
14PFE | PFIZER INC | Healthcare | $142.77B | 1.08% |
15APP | APPLOVIN CORP | Technology | $142.62B | 1.08% |
16SCCO | SOUTHERN COPPER CORP | Basic Materials | $142.48B | 1.08% |
17BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $124.04B | 0.94% |
18VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | $123.26B | 0.93% |
19TT | TRANE TECHNOLOGIES PLC | Basic Materials | $103.89B | 0.79% |
20NEM | NEWMONT CORP | Basic Materials | $95.76B | 0.73% |
21REGN | REGENERON PHARMACEUTICALS INC | Healthcare | $70.94B | 0.54% |
22MPWR | MONOLITHIC POWER SYSTEMS INC | Technology | $64.46B | 0.49% |
23FIX | COMFORT SYSTEMS USA INC | Industrials | $58.93B | 0.45% |
24CTVA | CORTEVA INC | Basic Materials | $58.39B | 0.44% |
25COHR | COHERENT CORP | Technology | $54.31B | 0.41% |
26KEYS | KEYSIGHT TECHNOLOGIES INC | Technology | $53.99B | 0.41% |
27ROK | ROCKWELL AUTOMATION INC | Industrials | $51.39B | 0.39% |
28TER | TERADYNE INC | Technology | $50.46B | 0.38% |
29XYZ | BLOCK INC | Technology | $47.58B | 0.36% |
30IDXX | IDEXX LABORATORIES INC | Healthcare | $44.76B | 0.34% |
31RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 0.30% |
32A | AGILENT TECHNOLOGIES INC | Healthcare | $37.13B | 0.28% |
33ROP | ROPER TECHNOLOGIES INC | Technology | $36.65B | 0.28% |
34WAT | WATERS CORP | Healthcare | $36.23B | 0.27% |
35ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $35.71B | 0.27% |
36ONC | BEONE MEDICINES LTD | Healthcare | $34.68B | 0.26% |
37RPRX | ROYALTY PHARMA PLC | Healthcare | $33.50B | 0.25% |
38MSTR | STRATEGY INC | Technology | $33.24B | 0.25% |
39KHC | KRAFT HEINZ CO | Consumer Defensive | $30.69B | 0.23% |
40FICO | FAIR ISAAC CORP | Technology | $29.15B | 0.22% |
41ILMN | ILLUMINA INC | Healthcare | $28.24B | 0.21% |
42MTD | METTLER TOLEDO INTERNATIONAL INC | Healthcare | $26.47B | 0.20% |
43ROIV | ROIVANT SCIENCES LTD | Healthcare | $24.82B | 0.19% |
44MRNA | MODERNA INC | Healthcare | $24.53B | 0.19% |
45INSM | INSMED INC | Healthcare | $23.48B | 0.18% |
46VLTO | VERALTO CORP | Industrials | $23.04B | 0.17% |
47STZ | CONSTELLATION BRANDS INC | Consumer Defensive | $22.69B | 0.17% |
48MKSI | MKS INC | Technology | $21.93B | 0.17% |
49FTV | FORTIVE CORP | Technology | $18.83B | 0.14% |
50NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.18B | 0.13% |
51LSCC | LATTICE SEMICONDUCTOR CORP | Technology | $17.16B | 0.13% |
52ONTO | ONTO INNOVATION INC | Technology | $13.92B | 0.11% |
53EVR | EVERCORE INC | Financial Services | $13.21B | 0.10% |
54PINS | PINTEREST INC | Communication Services | $13.00B | 0.10% |
55DT | DYNATRACE INC | Technology | $12.94B | 0.10% |
56TRMB | TRIMBLE INC | Technology | $12.29B | 0.09% |
57RVTY | REVVITY INC | Healthcare | $12.29B | 0.09% |
58PODD | INSULET CORP | Healthcare | $11.36B | 0.09% |
59TECH | BIO-TECHNE CORP | Healthcare | $11.29B | 0.09% |
60SMMT | SUMMIT THERAPEUTICS INC | Healthcare | $10.72B | 0.08% |
61CGNX | COGNEX CORP | Technology | $10.66B | 0.08% |
62HII | HUNTINGTON INGALLS INDUSTRIES INC | Industrials | $10.60B | 0.08% |
63ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | $10.47B | 0.08% |
64APGE | APOGEE THERAPEUTICS INC | Healthcare | $10.10B | 0.08% |
65DOCU | DOCUSIGN INC | Technology | $10.07B | 0.08% |
66NUVL | NUVALENT INC | Healthcare | $9.79B | 0.07% |
67HL | HECLA MINING CO | Basic Materials | $9.61B | 0.07% |
68HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.07% |
69IONS | IONIS PHARMACEUTICALS INC | Healthcare | $8.99B | 0.07% |
70BRKR | BRUKER CORP | Healthcare | $8.86B | 0.07% |
71CRNX | CRINETICS PHARMACEUTICALS INC | Healthcare | $8.84B | 0.07% |
72CHWY | CHEWY INC | Consumer Cyclical | $8.57B | 0.06% |
73RGEN | REPLIGEN CORP | Healthcare | $8.31B | 0.06% |
74BIO | BIO-RAD LABORATORIES INC | Healthcare | $8.15B | 0.06% |
75IBRX | IMMUNITYBIO INC | Healthcare | $8.04B | 0.06% |
76CAVA | CAVA GROUP INC | Consumer Cyclical | $8.02B | 0.06% |
77AVTR | AVANTOR INC | Basic Materials | $7.56B | 0.06% |
78YOU | CLEAR SECURE INC | Technology | $7.49B | 0.06% |
79PBF | PBF ENERGY INC | Energy | $7.42B | 0.06% |
80RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | $7.31B | 0.06% |
81CROX | CROCS INC | Consumer Cyclical | $6.81B | 0.05% |
82XENE | XENON PHARMACEUTICALS INC | Healthcare | $6.60B | 0.05% |
83ST | SENSATA TECHNOLOGIES HOLDING PLC | Technology | $6.55B | 0.05% |
84BYD | BOYD GAMING CORP | Consumer Cyclical | $6.52B | 0.05% |
85APPF | APPFOLIO INC | Technology | $6.36B | 0.05% |
86SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $6.33B | 0.05% |
87LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.08B | 0.05% |
88SEZL | SEZZLE INC | Financial Services | $5.87B | 0.04% |
89TWST | TWIST BIOSCIENCE CORP | Healthcare | $5.84B | 0.04% |
90CAR | AVIS BUDGET GROUP INC | Industrials | $5.67B | 0.04% |
91TXG | 10X GENOMICS INC | Healthcare | $5.55B | 0.04% |
92GTLB | GITLAB INC | Technology | $5.53B | 0.04% |
93PIPR | PIPER SANDLER COMPANIES | Financial Services | $5.42B | 0.04% |
94TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $5.27B | 0.04% |
95KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $4.92B | 0.04% |
96CNX | CNX RESOURCES CORP | Energy | $4.71B | 0.04% |
97SITE | SITEONE LANDSCAPE SUPPLY INC | Industrials | $4.60B | 0.03% |
98SYNA | SYNAPTICS INC | Technology | $4.41B | 0.03% |
99BMI | BADGER METER INC | Technology | $4.36B | 0.03% |
100VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.03% |
101VNT | VONTIER CORP | Technology | $4.25B | 0.03% |
102BOX | BOX INC | Technology | $4.22B | 0.03% |
103MIR | MIRION TECHNOLOGIES INC | Industrials | $4.00B | 0.03% |
104FOUR | SHIFT4 PAYMENTS INC | Technology | $3.99B | 0.03% |
105CRK | COMSTOCK RESOURCES INC | Energy | $3.92B | 0.03% |
106CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | $3.85B | 0.03% |
107PARR | PAR PACIFIC HOLDINGS INC | Energy | $3.82B | 0.03% |
108RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.03% |
109ITRI | ITRON INC | Technology | $3.81B | 0.03% |
110DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.03% |
111PVH | PVH CORP | Consumer Cyclical | $3.60B | 0.03% |
112ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.56B | 0.03% |
113OGN | ORGANON & CO | Healthcare | $3.55B | 0.03% |
114GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | $3.45B | 0.03% |
115WDFC | WD 40 CO | Basic Materials | $3.31B | 0.03% |
116PPLI | PEOPLE INC | Communication Services | $3.31B | 0.03% |
117AAP | ADVANCE AUTO PARTS INC | Consumer Cyclical | $3.19B | 0.02% |
118UAA | UNDER ARMOUR INC | Consumer Cyclical | $3.17B | 0.02% |
119CARG | CARGURUS INC | Consumer Cyclical | $3.16B | 0.02% |
120TRN | TRINITY INDUSTRIES INC | Industrials | $2.90B | 0.02% |
121RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $2.88B | 0.02% |
122TDC | TERADATA CORP | Technology | $2.87B | 0.02% |
123BKV | BKV CORP | Energy | $2.84B | 0.02% |
124WU | WESTERN UNION CO | Financial Services | $2.77B | 0.02% |
125VERA | VERA THERAPEUTICS INC | Healthcare | $2.76B | 0.02% |
126GPOR | GULFPORT ENERGY CORP | Energy | $2.75B | 0.02% |
127NGVT | INGEVITY CORP | Basic Materials | $2.66B | 0.02% |
128ATAI | ATAIBECKLEY INC | Healthcare | $2.66B | 0.02% |
129TARS | TARSUS PHARMACEUTICALS INC | Healthcare | $2.58B | 0.02% |
130GRDN | GUARDIAN PHARMACY SERVICES INC | Healthcare | $2.57B | 0.02% |
131AEHR | AEHR TEST SYSTEMS | Technology | $2.55B | 0.02% |
132QURE | UNIQURE NV | Healthcare | $2.54B | 0.02% |
133PBI | PITNEY BOWES INC | Industrials | $2.51B | 0.02% |
134CMPR | CIMPRESS PLC | Communication Services | $2.49B | 0.02% |
135SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $2.45B | 0.02% |
136COHU | COHU INC | Technology | $2.41B | 0.02% |
137VCEL | VERICEL CORP | Healthcare | $2.38B | 0.02% |
138BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.02% |
139BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.02% |
140HE | HAWAIIAN ELECTRIC INDUSTRIES INC | Utilities | $2.32B | 0.02% |
141NKTR | NEKTAR THERAPEUTICS | Healthcare | $2.31B | 0.02% |
142HCI | HCI GROUP INC | Financial Services | $2.27B | 0.02% |
143NEOG | NEOGEN CORP | Healthcare | $2.24B | 0.02% |
144IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | $2.23B | 0.02% |
145GT | GOODYEAR TIRE & RUBBER CO | Consumer Cyclical | $2.10B | 0.02% |
146SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.02% |
147ADMA | ADMA BIOLOGICS INC | Healthcare | $2.02B | 0.02% |
148INOD | INNODATA INC | Technology | $1.99B | 0.02% |
149ABCL | ABCELLERA BIOLOGICS INC | Healthcare | $1.97B | 0.01% |
150AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.01% |
151HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.96B | 0.01% |
152DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.01% |
153TYRA | TYRA BIOSCIENCES INC | Healthcare | $1.91B | 0.01% |
154PRG | PROG HOLDINGS INC | Industrials | $1.86B | 0.01% |
155ANIP | ANI PHARMACEUTICALS INC | Healthcare | $1.80B | 0.01% |
156IMCR | IMMUNOCORE HOLDINGS PLC | Healthcare | $1.78B | 0.01% |
157BL | BLACKLINE INC | Technology | $1.78B | 0.01% |
158INVX | INNOVEX INTERNATIONAL INC | Energy | $1.77B | 0.01% |
159HROW | HARROW INC | Healthcare | $1.74B | 0.01% |
160TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 0.01% |
161ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.01% |
162INVA | INNOVIVA INC | Healthcare | $1.60B | 0.01% |
163PUMP | PROPETRO HOLDING CORP | Energy | $1.59B | 0.01% |
164VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.01% |
165IDT | IDT CORP | Communication Services | $1.57B | 0.01% |
166XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | $1.52B | 0.01% |
167MLKN | MILLERKNOLL INC | Consumer Cyclical | $1.49B | 0.01% |
168ALNT | ALLIENT INC | Technology | $1.49B | 0.01% |
169MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.01% |
170DMC | DEL MONTE CORP | Consumer Defensive | $1.40B | 0.01% |
171CXM | SPRINKLR INC | Technology | $1.37B | 0.01% |
172BV | BRIGHTVIEW HOLDINGS INC | Industrials | $1.35B | 0.01% |
173PAHC | PHIBRO ANIMAL HEALTH CORP | Healthcare | $1.35B | 0.01% |
174XNCR | XENCOR INC | Healthcare | $1.30B | 0.01% |
175TTI | TETRA TECHNOLOGIES INC | Energy | $1.25B | 0.01% |
176TDAY | USA TODAY CO INC | Consumer Cyclical | $1.25B | 0.01% |
177HLF | HERBALIFE LTD | Consumer Defensive | $1.24B | 0.01% |
178NPKI | NPK INTERNATIONAL INC | Energy | $1.21B | 0.01% |
179AVO | MISSION PRODUCE INC | Consumer Defensive | $1.20B | 0.01% |
180QDEL | QUIDELORTHO CORP | Healthcare | $1.19B | 0.01% |
181COLL | COLLEGIUM PHARMACEUTICAL INC | Healthcare | $1.17B | 0.01% |
182SDGR | SCHRODINGER INC | Healthcare | $1.14B | 0.01% |
183SVRA | SAVARA INC | Healthcare | $1.13B | 0.01% |
184CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | $1.13B | 0.01% |
185NUTX | NUTEX HEALTH INC | Healthcare | $1.12B | 0.01% |
186WVE | WAVE LIFE SCIENCES LTD | Healthcare | $1.12B | 0.01% |
187UPWK | UPWORK INC | Industrials | $1.12B | 0.01% |
188EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.01% |
189JBIO | JADE BIOSCIENCES INC | Healthcare | $1.03B | 0.01% |
190AVTX | AVALO THERAPEUTICS INC | Healthcare | $1.02B | 0.01% |
191FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.01% |
192VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.01% |
193TBPH | THERAVANCE BIOPHARMA INC | Healthcare | $873M | 0.01% |
194SLDB | SOLID BIOSCIENCES INC | Healthcare | $859M | 0.01% |
195MATW | MATTHEWS INTERNATIONAL CORP | Industrials | $857M | 0.01% |
196CYRX | CRYOPORT INC | Industrials | $832M | 0.01% |
197TRNS | TRANSCAT INC | Industrials | $821M | 0.01% |
198RJET | REPUBLIC AIRWAYS HOLDINGS INC | Industrials | $806M | 0.01% |
199OPFI | OPPFI INC | Financial Services | $801M | 0.01% |
200HNRG | HALLADOR ENERGY CO | Basic Materials | $753M | 0.01% |
201IBTA | IBOTTA INC | Technology | $734M | 0.01% |
202AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.01% |
203OMER | OMEROS CORP | Healthcare | $701M | 0.01% |
204CRMD | CORMEDIX INC | Healthcare | $661M | 0.01% |
205FEIM | FREQUENCY ELECTRONICS INC | Technology | $650M | 0.00% |
206TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $648M | 0.00% |
207CWH | CAMPING WORLD HOLDINGS INC | Consumer Cyclical | $637M | 0.00% |
208TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.00% |
209NRDS | NERDWALLET INC | Communication Services | $609M | 0.00% |
210GYRE | GYRE THERAPEUTICS INC | Healthcare | $587M | 0.00% |
211MYGN | MYRIAD GENETICS INC | Healthcare | $584M | 0.00% |
212STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.00% |
213RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $555M | 0.00% |
214RLMD | RELMADA THERAPEUTICS INC | Healthcare | $550M | 0.00% |
215ELA | ENVELA CORP | Consumer Cyclical | $547M | 0.00% |
216MLAB | MESA LABORATORIES INC | Technology | $541M | 0.00% |
217KELYA | KELLY SERVICES INC | Industrials | $531M | 0.00% |
218ZURA | ZURA BIO LTD | Healthcare | $518M | 0.00% |
219XOMA | XOMA ROYALTY CORP | Healthcare | $504M | 0.00% |
220JOUT | JOHNSON OUTDOORS INC | Consumer Cyclical | $485M | 0.00% |
221SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $479M | 0.00% |
222MTW | MANITOWOC CO INC | Industrials | $468M | 0.00% |
223PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.00% |
224IDR | IDAHO STRATEGIC RESOURCES INC | Basic Materials | $449M | 0.00% |
225FSTR | FOSTER L B CO | Industrials | $439M | 0.00% |
226PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $434M | 0.00% |
227CBIO | CRESCENT BIOPHARMA INC | Healthcare | $407M | 0.00% |
228MCFT | MASTERCRAFT BOAT HOLDINGS INC | Consumer Cyclical | $407M | 0.00% |
229ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | $400M | 0.00% |
230ABEO | ABEONA THERAPEUTICS INC | Healthcare | $399M | 0.00% |
231CRNC | CERENCE INC | Technology | $390M | 0.00% |
232EOLS | EVOLUS INC | Healthcare | $377M | 0.00% |
233SLP | SIMULATIONS PLUS INC | Healthcare | $369M | 0.00% |
234ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.00% |
235NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $359M | 0.00% |
236LE | LANDS' END INC | Consumer Cyclical | $357M | 0.00% |
237ISSC | INNOVATIVE SOLUTIONS & SUPPORT INC | Industrials | $330M | 0.00% |
238VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.00% |
239BKTI | BK TECHNOLOGIES CORP | Technology | $307M | 0.00% |
240ALCO | ALICO INC | Consumer Defensive | $304M | 0.00% |
241TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.00% |
242UCFI | CN HEALTHY FOOD TECH GROUP CORP | Consumer Defensive | $288M | 0.00% |
243MASS | 908 DEVICES INC | Healthcare | $278M | 0.00% |
244OPRT | OPORTUN FINANCIAL CORP | Financial Services | $274M | 0.00% |
245TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.00% |
246ZSQR | Z SQUARED INC | Healthcare | $260M | 0.00% |
247SRZN | SURROZEN INC | Healthcare | $255M | 0.00% |
248SENS | SENSEONICS HOLDINGS INC | Healthcare | $214M | 0.00% |
249TNXP | TONIX PHARMACEUTICALS HOLDING CORP | Healthcare | $198M | 0.00% |
250SRI | STONERIDGE INC | Consumer Cyclical | $197M | 0.00% |
251EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $181M | 0.00% |
252KRRO | KORRO BIO INC | Healthcare | $177M | 0.00% |
253INSE | INSPIRED ENTERTAINMENT INC | Consumer Cyclical | $174M | 0.00% |
254ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.00% |
255INTT | INTEST CORP | Technology | $169M | 0.00% |
256LENZ | LENZ THERAPEUTICS INC | Healthcare | $162M | 0.00% |
257OWLT | OWLET INC | Healthcare | $162M | 0.00% |
258PED | PEDEVCO CORP | Energy | $161M | 0.00% |
259LGCY | LEGACY EDUCATION INC | Consumer Defensive | $154M | 0.00% |
260UNCY | UNICYCIVE THERAPEUTICS INC | Healthcare | $144M | 0.00% |
261HURC | HURCO COMPANIES INC | Industrials | $142M | 0.00% |
262VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.00% |
263CUE | CUE BIOPHARMA INC | Healthcare | $126M | 0.00% |
264SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.00% |
265MED | MEDIFAST INC | Consumer Cyclical | $114M | 0.00% |
266LAKE | LAKELAND INDUSTRIES INC | Consumer Cyclical | $113M | 0.00% |
267KEQU | KEWAUNEE SCIENTIFIC CORP | Consumer Cyclical | $109M | 0.00% |
268CPIX | CUMBERLAND PHARMACEUTICALS INC | Healthcare | $103M | 0.00% |
269ICCC | IMMUCELL CORP | Healthcare | $101M | 0.00% |
270VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.00% |
271OPXS | OPTEX SYSTEMS HOLDINGS INC | Industrials | $89M | 0.00% |
272GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.00% |
273RLYB | RALLYBIO CORP | Healthcare | $87M | 0.00% |
274CSBR | CHAMPIONS ONCOLOGY INC | Healthcare | $85M | 0.00% |
275FRMM | FORUM MARKETS INC | Healthcare | $83M | 0.00% |
276ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $76M | 0.00% |
277SCLX | SCILEX HOLDING CO | Healthcare | $72M | 0.00% |
278XLO | XILIO THERAPEUTICS INC | Healthcare | $53M | 0.00% |
279ACFN | ACORN ENERGY INC | Technology | $51M | 0.00% |
280TIL | INSTIL BIO INC | Healthcare | $50M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $13.20T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 81% toward Growth. +1% unclassified (22 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 280 names now. The faded start covers early months with a much thinner universe. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
Required>= 75.0%Actual54.7%Margin-20.3%No more than 25% of total assets may be invested in the securities of any one issuer.
Required<= 25.0%Actual37.2%Margin-12.2%The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual45.1%Margin-20.1%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 280 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 30.3% | -2.5% |
| 3 yearsp.a. | 33.4% | 9.6% |
| 5 yearsp.a. | 20.2% | 1.0% |
| 10 yearsp.a. | 16.8% | -0.3% |
| Since inceptionp.a. | 10.5% | -0.4% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 3.6% | -15.5% |
| 2025 | 36.3% | 21.3% |
| 2024 | 59.5% | 27.5% |
| 2023 | 29.4% | -3.8% |
| 2022 | -16.4% | -12.1% |
| 2021 | 14.7% | -8.4% |
| 2020 | 18.9% | 2.1% |
| 2019 | 20.9% | -4.5% |
| 2018 | -2.3% | 2.0% |
| 2017 | 18.5% | 4.7% |
| 2016 | 4.3% | -16.5% |
| 2015 | 1.3% | 4.1% |
| 2014 | 8.5% | 1.8% |
| 2013 | 27.3% | -10.2% |
| 2012 | 17.8% | -0.5% |
| 2011 | -2.1% | -5.1% |
| 2010 | 29.8% | 10.4% |
| 2009 | 20.8% | -16.2% |
| 2008 | -32.3% | 12.5% |
| 2007 | 8.4% | -10.5% |
| 2006 | 7.9% | -13.3% |
| 2005 | 6.7% | -0.9% |
| 2004 | 16.3% | -1.1% |
| 2003 | 40.2% | 1.7% |
| 2002 | -26.9% | 1.6% |
| 2001 | -13.6% | -5.5% |
| 2000 | -18.5% | -17.1% |
| 1999 | 80.9% | 76.4% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry ChTax Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a ChTax signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.